JP2014210807A5 - - Google Patents

Download PDF

Info

Publication number
JP2014210807A5
JP2014210807A5 JP2014157314A JP2014157314A JP2014210807A5 JP 2014210807 A5 JP2014210807 A5 JP 2014210807A5 JP 2014157314 A JP2014157314 A JP 2014157314A JP 2014157314 A JP2014157314 A JP 2014157314A JP 2014210807 A5 JP2014210807 A5 JP 2014210807A5
Authority
JP
Japan
Prior art keywords
contact lens
silicone hydrogel
hydrogel contact
nonionic silicone
chlorpheniramine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014157314A
Other languages
Japanese (ja)
Other versions
JP2014210807A (en
JP5689197B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2014157314A priority Critical patent/JP5689197B2/en
Priority claimed from JP2014157314A external-priority patent/JP5689197B2/en
Publication of JP2014210807A publication Critical patent/JP2014210807A/en
Publication of JP2014210807A5 publication Critical patent/JP2014210807A5/ja
Application granted granted Critical
Publication of JP5689197B2 publication Critical patent/JP5689197B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (3)

点眼剤に、（Ａ）クロルフェニラミン及びその塩からなる群より選択される少なくとも１種と（Ｂ）メントールとを配合し、且つ該（Ｂ）成分の配合割合を０．００１ｗ／ｖ％以上とすることを含む、該点眼剤に非イオン性シリコーンハイドロゲルコンタクトレンズへの角膜上皮細胞の接着を抑制する作用を付与する方法。In the eye drop, at least one selected from the group consisting of (A) chlorpheniramine and a salt thereof and (B) menthol are blended, and the blending ratio of the component (B) is 0.001 w / v% or more A method of imparting an effect of inhibiting the adhesion of corneal epithelial cells to a nonionic silicone hydrogel contact lens to the eye drop. （Ａ）クロルフェニラミン及びその塩からなる群より選択される少なくとも１種と、（Ｂ）メントールとを含有し、且つ該（Ｂ）成分の配合割合が０．００１ｗ／ｖ％以上である点眼剤からなる、非イオン性シリコーンハイドロゲルコンタクトレンズへの角膜上皮細胞接着抑制剤。Instillation containing (A) at least one selected from the group consisting of chlorpheniramine and a salt thereof, and (B) menthol, wherein the blending ratio of the component (B) is 0.001 w / v% or more. A corneal epithelial cell adhesion inhibitor to a nonionic silicone hydrogel contact lens, comprising an agent. （Ａ）クロルフェニラミン及びその塩からなる群より選択される少なくとも１種と、（Ｂ）メントールとを含有し、且つ該（Ｂ）成分の配合割合が０．００１ｗ／ｖ％以上である点眼剤からなる、非イオン性シリコーンハイドロゲルコンタクトレンズの装着時、装用時又は非イオン性シリコーンハイドロゲルコンタクトレンズを外す際の角膜上皮障害の抑制剤。Instillation containing (A) at least one selected from the group consisting of chlorpheniramine and a salt thereof, and (B) menthol, wherein the blending ratio of the component (B) is 0.001 w / v% or more. A suppressant for corneal epithelial disorder when a nonionic silicone hydrogel contact lens is worn, worn, or when the nonionic silicone hydrogel contact lens is removed.
JP2014157314A 2008-05-29 2014-08-01 Eye drops for nonionic silicone hydrogel contact lenses Active JP5689197B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014157314A JP5689197B2 (en) 2008-05-29 2014-08-01 Eye drops for nonionic silicone hydrogel contact lenses

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008141717 2008-05-29
JP2008141717 2008-05-29
JP2014157314A JP5689197B2 (en) 2008-05-29 2014-08-01 Eye drops for nonionic silicone hydrogel contact lenses

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009111976A Division JP5616589B2 (en) 2008-05-29 2009-05-01 Eye drops for nonionic silicone hydrogel contact lenses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015011916A Division JP2015091867A (en) 2008-05-29 2015-01-26 Eye drop for nonionic silicone hydrogel contact lens

Publications (3)

Publication Number Publication Date
JP2014210807A JP2014210807A (en) 2014-11-13
JP2014210807A5 true JP2014210807A5 (en) 2014-12-25
JP5689197B2 JP5689197B2 (en) 2015-03-25

Family

ID=41587689

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2009111976A Active JP5616589B2 (en) 2008-05-29 2009-05-01 Eye drops for nonionic silicone hydrogel contact lenses
JP2014157314A Active JP5689197B2 (en) 2008-05-29 2014-08-01 Eye drops for nonionic silicone hydrogel contact lenses
JP2015011916A Pending JP2015091867A (en) 2008-05-29 2015-01-26 Eye drop for nonionic silicone hydrogel contact lens
JP2016191784A Pending JP2016216520A (en) 2008-05-29 2016-09-29 Eye drops for nonionic silicone hydrogel contact lenses
JP2018169471A Pending JP2018188486A (en) 2008-05-29 2018-09-11 Eye drops for nonionic silicone hydrogel contact lenses
JP2020024274A Withdrawn JP2020073606A (en) 2008-05-29 2020-02-17 Eye drops for nonionic silicone hydrogel contact lenses
JP2021158606A Withdrawn JP2022001579A (en) 2008-05-29 2021-09-29 Eye drops for nonionic silicone hydrogel contact lenses
JP2023078010A Pending JP2023090938A (en) 2008-05-29 2023-05-10 Eye drops for nonionic silicone hydrogel contact lenses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009111976A Active JP5616589B2 (en) 2008-05-29 2009-05-01 Eye drops for nonionic silicone hydrogel contact lenses

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2015011916A Pending JP2015091867A (en) 2008-05-29 2015-01-26 Eye drop for nonionic silicone hydrogel contact lens
JP2016191784A Pending JP2016216520A (en) 2008-05-29 2016-09-29 Eye drops for nonionic silicone hydrogel contact lenses
JP2018169471A Pending JP2018188486A (en) 2008-05-29 2018-09-11 Eye drops for nonionic silicone hydrogel contact lenses
JP2020024274A Withdrawn JP2020073606A (en) 2008-05-29 2020-02-17 Eye drops for nonionic silicone hydrogel contact lenses
JP2021158606A Withdrawn JP2022001579A (en) 2008-05-29 2021-09-29 Eye drops for nonionic silicone hydrogel contact lenses
JP2023078010A Pending JP2023090938A (en) 2008-05-29 2023-05-10 Eye drops for nonionic silicone hydrogel contact lenses

Country Status (1)

Country Link
JP (8) JP5616589B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5616589B2 (en) * 2008-05-29 2014-10-29 ロート製薬株式会社 Eye drops for nonionic silicone hydrogel contact lenses
JP5355003B2 (en) * 2008-09-11 2013-11-27 ロート製薬株式会社 Eye drops for silicone hydrogel contact lenses
JP5627294B2 (en) * 2010-05-28 2014-11-19 ロート製薬株式会社 Contact lens ophthalmic composition
JP6353365B2 (en) * 2012-09-27 2018-07-04 千寿製薬株式会社 Aqueous liquid
JP5879410B2 (en) * 2014-09-19 2016-03-08 ロート製薬株式会社 Contact lens ophthalmic composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001187728A (en) * 1999-12-28 2001-07-10 Lion Corp Ophthalmic composition
JP4718160B2 (en) * 2003-11-12 2011-07-06 ロート製薬株式会社 Ophthalmic composition
JP2005309420A (en) * 2004-03-26 2005-11-04 Rohto Pharmaceut Co Ltd Composition for contact lenses
JP4856392B2 (en) * 2004-04-23 2012-01-18 ロート製薬株式会社 Preservative and aqueous composition containing the same
JP4776282B2 (en) * 2004-06-24 2011-09-21 ロート製薬株式会社 Contact lens composition
JP5201795B2 (en) * 2005-01-12 2013-06-05 ロート製薬株式会社 Pruritus inhibitor
JP4907388B2 (en) * 2006-02-28 2012-03-28 ロート製薬株式会社 Contact lens ophthalmic composition
JPWO2007145344A1 (en) * 2006-06-16 2009-11-12 ロート製薬株式会社 Ophthalmic composition for soft contact lenses containing terpenoid
JP2008024701A (en) * 2006-06-21 2008-02-07 Rohto Pharmaceut Co Ltd Composition for soft contact lens comprising alginic acid or salt thereof
JP5616589B2 (en) * 2008-05-29 2014-10-29 ロート製薬株式会社 Eye drops for nonionic silicone hydrogel contact lenses
JP5568246B2 (en) * 2008-06-04 2014-08-06 ロート製薬株式会社 Eye drops for nonionic silicone hydrogel contact lenses
JP5595683B2 (en) * 2008-07-10 2014-09-24 ロート製薬株式会社 Eye drops for ionic silicone hydrogel contact lenses

Similar Documents

Publication Publication Date Title
JP2014210807A5 (en)
EP3525885A4 (en) Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
JP2013006877A5 (en)
JP2014012746A5 (en)
WO2016029191A3 (en) Channel modulators
IL245117A0 (en) Co-crystals of (s)-n-methyl-8-(1-((2'-methyl-[4,5'-bipyrimidin]-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof, methods of producing same, compositions comprising same and uses thereof
JP2014139241A5 (en)
BR112015001847A2 (en) compositions and treatment for eye diseases and disorders
MX2017002374A (en) Compositions and methods to treat vision disorders.
JP2014211652A5 (en)
JP2020070301A5 (en)
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
JP2011136986A5 (en)
AU2015352158A8 (en) Medicaments for slowing Parkinson's Disease
IL273531A (en) Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
JP2011132227A5 (en)
RU2016136333A (en) PHARMACOLOGICAL OPHTHALMOLOGICAL COMPOSITION USED IN CORRECTION OF PRESBIOPIA AND ITS INTRODUCTION
JP2014210813A5 (en)
MX2016009495A (en) Aqueous composition suitable for cleaning and protection comprising silica nanoparticles, copolymer of acrylamide and acrylic acd, nonionic and anionic surfactant.
WO2016015055A8 (en) Colon cleansing compositions
NZ767710A (en) Ocular formulations for drug-delivery and protection of the anterior segment of the eye
WO2016011297A3 (en) Methods and related compositions for improved drug bioavailability and disease treatment
JP2011098961A5 (en)
ZA202003944B (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
MX2015012716A (en) Compositions for use in treating eye disorders using dipyridamole.